Leadership

Faculty


Regis B. Kelly, PhD—Director

Prior to joining QB3 in 2004, Regis Kelly served as executive vice-chancellor at UCSF; he oversaw the UCSF research enterprise and was also responsible for construction of the new Mission Bay campus. He was chairman of the Bay Area Scientific Innovation Consortium and has served on the boards of the Malaysian Biotechnology Industry Advisory Board, the Scleroderma Foundation, and Bridge Pharmaceuticals. He is an advisor to the Thailand Bionanotechnology Institute, Ho Chi Minh City Biotechnology Department Corp., University of Oxford Systems Biology Program, and the San Francisco Mayor’s Biotechnology Advisory Group. He joined the UCSF Department of Biochemistry in 1971 and has served as director of the Cell Biology Graduate Program, director of the Hormone Research Institute, and chair of the Department of Biochemistry and Biophysics. He earned an undergraduate degree in physics from the University of Edinburgh and a PhD in biophysics from the California Institute of Technology. Email



David Haussler, PhD—Director, QB3-Santa Cruz

David Haussler holds a UC Presidential Chair in Computer Science, is director of the Center for Biomolecular Science & Engineering at UC Santa Cruz, and is a Howard Hughes Medical Institute (HHMI) Investigator. He earned his undergraduate degree in mathematics from Connecticut College, and his PhD in computer science from the University of Colorado at Boulder. David Haussler’s webpage Email



Susan Marqusee, MD, PhD—Director, QB3-Berkeley

Susan Marqusee is a professor of molecular and cell biology in UC Berkeley’s Division of Biochemistry and Molecular Biology. She received her AB in physics and chemistry from Cornell University, and her MD and PhD degrees from Stanford University. After a postdoctoral fellowship at MIT, she joined the UC Berkeley faculty. Susan Marqusee’s webpage Email


Nevan Krogan, PhD—Director, QB3-UCSF

Nevan Krogan is professor of cellular and molecular pharmacology at UC San Francisco and associate investigator at the Gladstone Institutes. He received a BSc in chemistry and MSc in biochemistry from the University of Regina and a PhD in medical genetics from the University of Toronto. After a fellowship with the Sandler Institute, he joined the UCSF faculty in 2007. Email

Innolab


Crawford headshot_sm.jpg

Douglas Crawford, PhD—Associate Director, QB3; Managing Director, Mission Bay Capital; General Partner, QB3 Incubator Partners

Douglas Crawford’s goal is to help entrepreneurial scientists create successful startups to meet California’s needs for better health, a sustainable environment, and economic growth—particularly jobs. To this end, Crawford and his colleagues have systematically lowered the barriers between great ideas and successful companies. For instance, Crawford created and manages the first incubator within the University of California, the QB3 Garage@UCSF. The QB3 incubator program has now grown to five sites and 62 companies, and he has created a partnership to build a new 24,000 square foot life-science incubator in Mission Bay. More recently, QB3 created a program to help entrepreneurs create companies to pursue government grants and private funding. In the first 16 months this program has helped launch 115 companies, 25 of which are already operational. Crawford is also a founder and managing director of Mission Bay Capital, an $11.3M seed-stage venture fund that makes pivotal early-stage investments in bioscience companies. He is a board member of Atreca (observer), Delpor, Ethonova, and Redwood Biosciences (observer). Crawford received his PhD in biochemistry from UCSF. Email


neena_thumb.jpg

Neena Kadaba, PhD—Director, Industry Alliances

Neena Kadaba works to initiate new collaborations between industry and QB3 campus scientists and manages QB3’s multi-year, multimillion dollar alliance with Pfizer. She runs the Quadrant industry speakers seminar series to link scientists from industry to scientists in academia and startups, and manages QB3’s internship program. Previously, she co-founded Cypress Innovations and was an associate and Kauffman Fellow in the venture capital group at Itochu Technology. She earned her BS at the Massachusetts Institute of Technology and her PhD in chemistry at the California Institute of Technology. Email


Kaspar Mossman, PhD—Communications Director

Kaspar Mossman engages internal and external stakeholders in QB3’s mission to support research and commercialization in quantitative biosciences. He manages the QB3 website, newsletter, email and event marketing, multimedia, social media, and print publications. Previously, he worked on the media staff at Proceedings of the National Academy of Sciences and held an AAAS mass media fellowship at Scientific American. He earned a PhD in biophysics from UC Berkeley. Email


Adriana Tajonar, PhD—Entrepreneurship Program Manager

Adriana Tajonar manages the QB3 Startup in a Box and QB3 Accelerator programs, a core part of QB3’s initiative to help launch life science companies and set them up for operational success. Before QB3, Adriana earned a PhD in biological and biomedical sciences from Harvard University and a BS in biology from MIT. Email


Christine Winoto—Assistant Director

Christine Winoto manages QB3’s finance and operations. Before joining QB3, she developed marketing strategy and analyzed performance for Kaiser Permanente, and managed business development and financial analysis at Genencor. She has consulted for startups and venture capital, and holds an MBA from Erasmus University in the Netherlands and a BS in food chemistry from the University of Wisconsin, Madison. Email